Since both cancer cells and cells of the microenvironment are responsive to CCL8, we sought to explore the effects of DTCCL8 in mouse breast cancer in mice that possess intact immune system, as opposed to human breast cancer xenografts at which the host's immune system is compromised. This evidence concerns the gene CCL8 and breast carcinoma.